Top 10 Healthcare Market Research Firms in Asia-Pacific (APAC)

 The Asia-Pacific (APAC) healthcare industry is evolving rapidly, driven by rising patient populations, fast-growing pharmaceutical markets, accelerated digital transformation, and increasing investment in medical technologies. As opportunities expand, so does the need for reliable and data-driven market insights. Healthcare market research firms play a critical role in helping pharmaceutical companies, medical device manufacturers, digital health innovators, and investors make strategic decisions with clarity and precision.

This article provides an authoritative overview of the Top 10 Healthcare Market Research Firms in APAC, recognized for their expertise, analytical strength, regional presence, and the value they deliver to industry stakeholders. Each organization listed is a trusted partner to healthcare leaders navigating the region’s complex and diverse markets.

1. IQVIA

IQVIA is one of the most influential healthcare insights companies worldwide and a dominant force in the APAC region. Leveraging advanced analytics, real-world evidence, AI-driven technologies, and one of the largest healthcare datasets in the world, IQVIA provides unmatched intelligence across the full pharmaceutical and medtech value chain.

With operations spanning China, India, South Korea, Japan, Singapore, Australia, and broader Southeast Asia, IQVIA supports companies with strategic planning, market entry guidance, competitive intelligence, clinical trial optimization, and commercialization support.

Its deep integration of data science, technology platforms, and healthcare domain expertise positions it as the premier choice for organizations seeking comprehensive, reliable, and actionable market intelligence.

2. Frost & Sullivan

Frost & Sullivan has long been known for its strategic growth advisory services across industries, and healthcare is one of its strongest domains in APAC. The firm excels in identifying emerging opportunities, disruptive technologies, and innovation landscapes across pharmaceuticals, diagnostics, medical devices, and digital health.

Its expert teams provide competitive benchmarking, future market forecasts, and strategic consulting that help companies identify high-potential markets and technology adoption trends. Frost & Sullivan’s regional coverage across Australia, Southeast Asia, China, and India makes it a key partner for firms evaluating long-term growth opportunities.

3. Kantar Health

Kantar Health is widely respected for its global expertise in epidemiology, patient insights, oncology analytics, and health economics. The firm offers strong capabilities in data-driven insights that blend research science with human experience, providing clarity across brand performance, patient behavior, and treatment landscapes.

Kantar Health’s footprint across Japan, China, India, and South Korea allows it to provide in-depth, localized analysis in markets with significant cultural and healthcare system diversity. Its understanding of real-world patient journeys makes it highly valuable to pharmaceutical and biotech firms developing patient-centric strategies.

4. DelveInsight

DelveInsight is a leading healthcare market research and consulting firm highly regarded for its deep specialization in pharmaceutical intelligence, epidemiology forecasting, pipeline assessments, and therapeutic landscape analysis. The company offers a portfolio of over 10,000 reports covering more than 45 therapy areas, making it a trusted source for detailed disease and drug analytics.

In APAC, DelveInsight is recognized for its ability to analyze emerging drug markets, competitive dynamics, and clinical activity trends with precision. Its strengths include robust epidemiology models, granular forecasting, and insights tailored specifically to the needs of biopharma innovators and investors.

The firm’s data-driven approach helps healthcare stakeholders better understand unmet needs, evaluate commercial potential, and plan strategic market entry across the region.

5. GlobalData Healthcare

GlobalData Healthcare provides end-to-end intelligence across pharmaceuticals, healthcare services, medical devices, and clinical research. Its comprehensive data platform—integrating clinical trials, regulatory updates, epidemiology, and competitor intelligence—is widely used by industry leaders.

In APAC, GlobalData’s analysis of healthcare reforms, shifting patient demographics, cost-containment initiatives, and digital health adoption has made it an essential partner for multinational and regional companies alike. The company delivers accurate forecasts and competitive insights that support product strategy, investment planning, and R&D decision-making.

6. Ipsos Healthcare

Ipsos Healthcare is known for its excellence in market research focused on patient and physician insights. Its methodologies blend behavioral science, quantitative research, and qualitative studies to capture nuanced perspectives that influence healthcare decision-making.

The organization’s strong presence in markets like Japan, China, South Korea, Vietnam, India, and Australia enables it to capture diverse stakeholder experiences. Ipsos Healthcare’s expertise spans major therapeutic areas, including oncology, immunology, rare diseases, and neurology.

Its ability to translate complex human experiences into strategic business intelligence makes it especially valuable to companies developing commercial strategies and patient engagement initiatives.

7. NielsenIQ (Healthcare Division)

NielsenIQ is a leading authority in consumer behavior analysis, and its healthcare division uses this strength to provide powerful insights into consumer health trends, OTC drug consumption, and pharmaceutical retail activities.

Its vast network of pharmacy and retail data across APAC offers unparalleled visibility into purchasing patterns, brand performance, and market shifts. NielsenIQ is particularly valuable for companies operating in consumer health, supplements, wellness products, and OTC categories.

Its analytics platforms help organizations track market share, monitor competition, and understand nationwide retail dynamics with accuracy.

8. MarketsandMarkets

MarketsandMarkets is known for its comprehensive global research coverage and detailed market segmentation across pharmaceuticals, medtech, biotechnology, diagnostics, and healthcare IT. Its APAC-focused research provides forward-looking insights into high-growth areas, including genomics, telemedicine, AI-driven healthcare, regenerative medicine, and remote monitoring.

The firm specializes in identifying emerging pockets of opportunity and delivering actionable intelligence that supports investment strategy, product expansion, and competitive positioning.

MarketsandMarkets’ large library of syndicated reports and custom consulting capabilities make it a widely used resource for businesses evaluating growth potential in APAC.

9. Research & Markets (Healthcare Division)

Research & Markets is a major provider of aggregated market intelligence, offering one of the largest collections of healthcare research reports globally. Its healthcare division compiles insights across pharmaceuticals, medical devices, diagnostics, population health, and digital health trends.

Its APAC-focused reports draw on the expertise of regional analysts and industry specialists, making it a useful source of accessible and diverse information. Companies often rely on Research & Markets for high-level strategic overviews, market sizing, and country-specific market evaluations.

10. Grand View Research

Grand View Research has developed a strong presence in the APAC healthcare research landscape due to its detailed analysis, advanced forecasting methodologies, and comprehensive market modeling.

The firm covers a broad spectrum of healthcare sectors, including precision medicine, imaging technologies, biotechnology tools, chronic disease management, and digital therapeutics. Its APAC studies help companies understand competitive pressures, market drivers, and technological advancements within the region’s rapidly evolving healthcare ecosystem.

Grand View Research’s insights are particularly valuable for long-term planning, investment analysis, and market entry assessments.

Why Market Research Is Critical in APAC’s Healthcare Sector

The APAC region is one of the most dynamic markets in the world, and healthcare transformation is accelerating. Companies rely on trusted market research partners to navigate:

Rapid Epidemiological Shifts

Chronic conditions such as cancer, diabetes, respiratory illnesses, and cardiovascular diseases are growing rapidly, increasing demand for innovative treatments and technologies.

Evolving Regulatory and Policy Structures

APAC markets vary widely in their regulatory frameworks. Accurate intelligence is essential for product approvals, pricing, reimbursement, and compliance.

Fast Digital Health Adoption

Countries across APAC are embracing telehealth, AI-driven diagnostics, hospital automation, and patient-management technologies at unprecedented speed.

Expanding Healthcare Infrastructure

Government investments in hospitals, diagnostics centers, pharmaceuticals, and medtech manufacturing are reshaping market demand.

Growing Clinical Trial Activity

APAC is becoming a top global destination for clinical research due to patient availability and lower trial costs, making it crucial to track pipeline developments and competitor activities.

How to Select the Right Market Research Partner in APAC

When choosing a firm, healthcare executives should consider:

Regional Footprint

A firm with strong on-ground presence and local expertise will provide more accurate, culturally relevant insights.

Data Integrity and Methodology

Reliable research requires transparent methodologies, validated data sources, and rigorous analytical frameworks.

Therapeutic Expertise

Deep specialization in specific disease areas ensures more meaningful and actionable insights.

Customization Options

Tailored research solutions offer higher strategic value than generalized findings.

Forecasting and Competitive Intelligence

Robust forecasting models help organizations anticipate future market changes and respond proactively.

Final Thoughts

As the APAC healthcare market continues its rapid transformation, the demand for accurate, actionable market intelligence becomes increasingly critical. The top firms listed above—including global leaders like IQVIA and regional specialists like DelveInsight—equip organizations with the tools and insights they need to navigate regulatory complexities, evaluate emerging opportunities, and make strategic investments that drive long-term success.

Whether you are expanding product portfolios, entering new markets, launching innovative therapies, or identifying unmet medical needs, partnering with a strong healthcare market research firm is essential for informed decision-making in the Asia-Pacific region.